Equipment certification plays a crucial role in maintaining and improving image quality in clinical trials. Learn how it impacts the overall quality of imaging in our info sheet....
Equipment certification plays a crucial role in maintaining and improving image quality in clinical trials. Learn how it impacts the overall quality of imaging in our info sheet....
Deciding it’s time to engage a new clinical endpoint service provider is never easy, but sometimes it’s necessary. Your current provider may not have the experience or scalability you need to move your programs ahead....
Endothelial Cell Count (ECC) is an important measurement to evaluate corneal endothelial cell health. MERIT provides masked, independent ECC reading, as required in many ocular clinical trials....
Not all technology platforms are created equal. MERIT’s EXCELSIOR™ system not only increases accuracy and efficiency by providing a suite of advanced endpoint analysis tools, but it also provides the regulatory assurance of FDA 510(k) clearance. Learn what benefits FDA 510(k) clearance offers in our...
MERIT’s ISO 13485 certification of our Quality Management System provides more than just regulatory compliance. It demonstrates our commitment to quality, safety, efficiency, and consistency. Read our info sheet to learn the advantages of collaborating with an ISO 13485 certified company like MERIT....
MERIT’s cloud-based EXCELSIOR software platform enables easy upload of oncology images (CT, MRI, PET) to one secure, validated and FDA-cleared application. This facilitates real-time, trackable, and transparent communication. Learn more in our info sheet....
MERIT is a global clinical trial endpoint services provider offering reliable and attentive expertise in our therapeutic areas. Learn more about what sets MERIT apart in this info sheet....
Gene therapy trials in Inherited Retinal Diseases (IRDs) present unique challenges for biopharma drug developers. Choosing MERIT as your clinical endpoint expert gives you access to solutions based on experience supporting 31 gene therapy trials in IRDs....
What if your company’s early meetings with the FDA to review your preclinical data have indicated a need for ophthalmology safety endpoints in your upcoming non-ophthalmology clinical trial? Discover what your next steps should be in this info sheet....
Many full-service CROs have elected to integrate and use our solutions to manage the imaging and data management elements of their clinical studies. We are thoroughly familiar with the hurdles that CROs may face and can help you proactively address them to meet your customers’...
MERIT’s commitment to quality is the foundation of our safe, reliable, and efficient data analysis and management services for clinical trials. Discover the four cornerstones of MERIT services in this info sheet....
MERIT’s ophthalmic expertise and cloud-based imaging platform performed a crucial role in a global Phase III Wet AMD study. Take a look at a few key metrics from our case study....